Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/13/2003US20030032035 Apparatus for use in analysis of protein and nucleotide sequences
02/13/2003US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection
02/13/2003US20030032031 Diagnosing liver defects in humans; obtain fluid sample, determine concentration of viral core protein present, evaluate for liver defects
02/13/2003US20030032030 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging
02/13/2003US20030032026 Detection and measurement of methylated cytosine in nucleic acid sample; obtain genomic nucleotide sequences, incubate with reaction mixture and label, amplifiy nucleotide sequences, detect and quantify fluorescence
02/13/2003US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
02/13/2003US20030032018 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like.
02/13/2003US20030032013 Apparatus for use in the isolation, harvesting, detection and/or quantifying target bioplymers
02/13/2003US20030032008 Immunoassay reagent for use in diagnosis and detection of viral infection
02/13/2003US20030032007 Method of detecting microorganisms in a sample
02/13/2003US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
02/13/2003US20030032004 Primers and probes derived from the 5' untranslated region of the HCV genome which facilitate detection and/or quantification of all presently known genotypes of HCV.
02/13/2003US20030032002 Screening cells for preferential cell activity; obtain cells insert into monitoring apparatus, detect preferential activity, separate cells expressing preferential activity
02/13/2003US20030032000 Method for analyzing cellular events
02/13/2003US20030031783 Silica adsorbent on magnetic substrate
02/13/2003US20030031685 Pure allergen component
02/13/2003US20030031673 Treatment and diagnosis of cancer
02/13/2003US20030031672 Individualized anti-cancer antibodies
02/13/2003US20030031670 Diagnosis and treatment of malignant neoplasms
02/13/2003US20030031667 Human monoclonal antibodies to dendritic cells
02/13/2003US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke
02/13/2003US20030031657 Stem cells and their use in transplantation
02/13/2003US20030031625 Detecting the presence of small intestinal bacterial overgrowth in a human subject having at least one symptom associated with a suspected diagnosis of the condition caused by small intestinal bacterial overgrowth
02/13/2003US20030031599 For testing sample of blood
02/13/2003US20030031597 Apparatus for measuring glucose concentration
02/13/2003US20030031595 Used in analyzing blood glucose or other analytes contained therein
02/13/2003US20030031594 Vacuum loaded test strip with stop junction and bypass channel
02/13/2003US20030031592 Spreading layers, wetting agents for their production and their use in test strips
02/13/2003US20030031591 Sensor release for a blood glucose sensor dispensing instrument
02/13/2003US20030031352 Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease
02/13/2003US20030031350 Methods for large scale protein matching
02/13/2003US20030030810 Optical debris analysis fixture
02/13/2003US20030030784 Method of classifying particles on two-dimensional frequency distribution map and blood analyzer utilizing the same
02/13/2003US20030030783 Consumable tube for use with a flow cytometry-based hematology system
02/13/2003US20030030450 Test method and apparatus for determining the surface saturated dry condition of aggregates
02/13/2003US20030030184 Method of making device for arraying biomolecules and for monitoring cell motility in real-time
02/13/2003US20030029722 Reference electrode
02/13/2003US20030029714 Manipulation of solid, semi-solid or liquid materials
02/13/2003US20030029640 Method for determining drilling fluid properties downhole during wellbore drilling
02/13/2003US20030029254 Blood analyzer
02/13/2003US20030029234 Fuel driveability index sensor and method
02/13/2003US20030029231 Mobile hand-held unit comprising a reusable biosensor
02/13/2003US20030028981 Precision fluorescently dyed particles and methods of making and using same
02/13/2003DE19938138C2 Verfahren und Vorrichtung zur Identifikation einer Biopolymersequenz auf Festkörperoberflächen Method and apparatus for identifying a biopolymer on solid surfaces
02/13/2003CA2456821A1 Human zona pellucida proteins and methods of their use in diagnosing male infertility
02/13/2003CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003CA2456184A1 Expression profile of prostate cancer
02/13/2003CA2456105A1 Modular assembly of nucleic acid-protein fusion multimers
02/13/2003CA2456003A1 Regulator of calcineurin
02/13/2003CA2455921A1 Non-destructive joint sealant testing device
02/13/2003CA2455916A1 Prediction models for molecular activity and protein binding
02/13/2003CA2455877A1 Apparatus and method for determining the onset and presence of sepsis conditions
02/13/2003CA2455836A1 Method and device for predicting the fertile phase of women
02/13/2003CA2455813A1 Method and system for predicting initial analyte values in stored samples
02/13/2003CA2455812A1 Method and means for detecting internal larval infestation in granular material
02/13/2003CA2455700A1 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003CA2455647A1 Enhancing organ maturity in neonates and predicting their duration of intensive care
02/13/2003CA2455398A1 Use of peptide fragments of the calcium channel .alpha.-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
02/13/2003CA2455237A1 Compositions and methods for generating chimeric heteromultimers
02/13/2003CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity
02/13/2003CA2455147A1 Pregnancy-related enzyme activity
02/13/2003CA2454937A1 Modulators of notch signalling for use in immunotherapy
02/13/2003CA2454850A1 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003CA2454700A1 A method to analyze nucleic acid(s) defining gene(s) exhibiting altered expression by schizophrenia
02/13/2003CA2454454A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/13/2003CA2454421A1 Use of long pentraxin ptx3 for treating female infertility
02/13/2003CA2454238A1 Method of detecting protease activity in a cell
02/13/2003CA2454088A1 Method for selecting antibody expressing cells
02/13/2003CA2454066A1 Pulmonary formulation
02/13/2003CA2453526A1 Intra-vaginal self-administered cell collecting device and method
02/13/2003CA2452547A1 System and method for quantitative assessment of joint diseases and the change over time of joint diseases
02/13/2003CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003CA2407299A1 Peptide sequence tags and method of using same
02/13/2003CA2397516A1 Blood glucose sensor dispensing instrument having a pull/push activation mechanism
02/13/2003CA2397514A1 Sensor release for a blood glucose sensor dispensing instrument
02/13/2003CA2397511A1 Blood glucose sensor dispensing instrument having a modular electronics assembly
02/13/2003CA2397412A1 Mechanical mechanism for a blood glucose sensor dispensing instrument
02/12/2003EP1283420A1 Method and apparatus for measuring a hydrocarbon concentration in water
02/12/2003EP1283418A2 Capacitive fuel sensor and method
02/12/2003EP1283272A2 Methods and means for assessing HIV envelope inhibitor therapy
02/12/2003EP1283271A1 Method of screening compounds using nematode worms
02/12/2003EP1283270A1 Supported membrane, preparation and use
02/12/2003EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
02/12/2003EP1283258A1 Ornithine decarboxylase similar protein and nucleic acid molecules encoding it
02/12/2003EP1283212A1 Methods for identifying compounds that bind to a target
02/12/2003EP1283059A2 Therapeutic conjugates of toxins and drugs
02/12/2003EP1283058A1 Agents for preventing or ameliorating insulin resistance and/or obesity
02/12/2003EP1283057A1 Cell proliferation inhibitors
02/12/2003EP1283053A1 Inhibitors of HER3 activity
02/12/2003EP1283023A1 Recording medium and blood glucose monitoring system
02/12/2003EP1282826A2 Lead molecule generation
02/12/2003EP1282825A1 Immunoassay for cereal reserve protein
02/12/2003EP1282824A2 Doped nanoparticles as biolabels
02/12/2003EP1282823A2 Proteolytic enzymes in diagnosis of kidney disorders
02/12/2003EP1282822A2 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
02/12/2003EP1282821A2 Identification of nuclear receptor-dependent coregulator recruitment
02/12/2003EP1282820A1 Assay device with timer function
02/12/2003EP1282819A1 Method for immobilizing recognition components
02/12/2003EP1282818A2 Method and reagents for investigating functional molecular interactions
02/12/2003EP1282817A1 Monoreagent for assaying platelet-derived microparticles